|
2011
New Test Information Index
Drug
Screening for Pain Management
Medications
Technical
Bulletin
Drug Screens
 Pain
Management
A routine drug screen
uses an opiate cut-off of 2000 ng/ml.
It is designed to detect abusers and
will miss patients taking oxycodone
or other opiates taken as prescribed.
We have a new, low cost urine screen
for checking compliance for commonly
prescribed pain medications. The panel
consists of:
- Opiates
(300ng/ml cut-off)
- Oxycodone
- Methadone
metabolite
- Buprenorphine
This
is a sensitive test that will detect
normally prescribed dosages of pain
medication. Results will not automatically
be confirmed by GC/MS. This test was
developed at physicians’ request
to provide a cost effective
tool for assuring a patient
is taking prescribed pain medication.
The test requires a single
urine collection, collected
like a routine drug
screen. The test name is PAIN
MANAGEMENT PANEL, and
the test code is PAIN.
New
Federal Guidelines
Federal
Register/ Vol. 75 No. 157/
August 16, 2010/Rules
and Regulations:
Urine
drug screens that test for opiates
must
include 6-acetlymorphine
(abbreviated
6-AM). 6-AM is
heroin metabolite.
Urine
drug screens
that test
for
amphetamine
and methamphetamine
must
now
include Ecstasy.
AMS Lab already
includes Ecstasy
on its drug
screens,
but will add
6-AM. Additional changes
in the rules
that have already
been implemented
at
AMS are the screening
and
confirmation
cut-offs have been lowered
for amphetamine,
methamphetamine,
MDA, MDMA, MDEA,
and
cocaine metabolite.
| Top of Page |
|
